| human | Q5 |
| P496 | ORCID iD | 0000-0003-4388-2173 |
| P69 | educated at | Nanjing Medical University | Q6963668 |
| Tianjin Medical University | Q834827 | ||
| P108 | employer | Sun Yat-sen University | Q178972 |
| P106 | occupation | researcher | Q1650915 |
| Q92190065 | A one-step specific assay for continuous detection of sirtuin 2 activity |
| Q53431629 | Advanced glycation end products induced immune maturation of dendritic cells controls heart failure through NF-κB signaling pathway. |
| Q90403441 | Angiopoietin-2 induces angiogenesis via exosomes in human hepatocellular carcinoma |
| Q42800518 | Aspirin Increases Apolipoprotein-A-I-Mediated Cholesterol Efflux via Enhancing Expression of ATP-Binding Cassette Transporter A1 |
| Q90744416 | Calcium Signal Pathway is Involved in Prostaglandin E2 Induced Cardiac Fibrosis in Cardiac Fibroblasts |
| Q92435741 | Chrysophanol protects against doxorubicin-induced cardiotoxicity by suppressing cellular PARylation |
| Q92633740 | Cryptotanshinone protects against pulmonary fibrosis through inhibiting Smad and STAT3 signaling pathways |
| Q39001729 | Cyclovirobuxine D induces autophagy-associated cell death via the Akt/mTOR pathway in MCF-7 human breast cancer cells |
| Q64374700 | Dkk1 exacerbates doxorubicin-induced cardiotoxicity by inhibiting the Wnt/β-catenin signaling pathway |
| Q112580942 | HO-1 nuclear accumulation and interaction with NPM1 protect against stress-induced endothelial senescence independent of its enzymatic activity |
| Q39671174 | Icariin Derivative Inhibits Inflammation through Suppression of p38 Mitogen-Activated Protein Kinase and Nuclear Factor-.KAPPA.B Pathways |
| Q42792047 | Mitogen-activated protein kinases ERK 1/2- and p38-GATA4 pathways mediate the Ang II-induced activation of FGF2 gene in neonatal rat cardiomyocytes |
| Q51246484 | NMNAT3 is involved in the protective effect of SIRT3 in Ang II-induced cardiac hypertrophy. |
| Q64376823 | PARP1 interacts with HMGB1 and promotes its nuclear export in pathological myocardial hypertrophy |
| Q38134049 | Poly(ADP-ribose) polymerase 1 (PARP1) in atherosclerosis: from molecular mechanisms to therapeutic implications |
| Q33872909 | Rapamycin attenuated cardiac hypertrophy induced by isoproterenol and maintained energy homeostasis via inhibiting NF-κB activation |
| Q92752474 | SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function |
| Q58555570 | SIRT1 represses PKC-zeta activity via regulating interplay of acetylation and phosphorylation in cardiac hypertrophy |
| Q48779661 | SIRT3 prevents angiotensin II-induced renal tubular epithelial-mesenchymal transition by ameliorating oxidative stress and mitochondrial dysfunction |
| Q60916592 | SIRT6 Suppresses NFATc4 Expression and Activation in Cardiomyocyte Hypertrophy |
| Q40695454 | STAT3 Suppression Is Involved in the Protective Effect of SIRT6 Against Cardiomyocyte Hypertrophy |
| Q40648753 | TIEG1 Inhibits Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting Transcription Factor GATA4. |
| Q91791939 | Vps4A mediates the localization and exosome release of β-catenin to inhibit epithelial-mesenchymal transition in hepatocellular carcinoma |
| Q89508085 | mTORC2 facilitates endothelial cell senescence by suppressing Nrf2 expression via the Akt/GSK-3β/C/EBPα signaling pathway |
| Q58093002 | sFRP1 has a biphasic effect on doxorubicin-induced cardiotoxicity in a cellular location-dependent manner in NRCMs and Rats |
Search more.